跳至主要内容
临床试验/CTRI/2022/12/048303
CTRI/2022/12/048303尚未招募3 期

Evaluation of comparative efficacy of Eladi kasaya versus Tab Tranexamic acid in the management of Asrigdara (Heavy menstrual bleeding).

Mahatma gandhi ayurved college, hospital and research centre0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients who are willing to give written consent for the trial.
  • 2. Patients between the age group of 18 to 45years.
  • 3. Patients with excessive bleeding ( >80ml) for at least 2 consecutive cycles.

排除标准

  • 1. Patients with any diagnosed uterine organic pathology like Uterine Fibroid, Adenomyosis, Chronic tubo ovarian mass. Polycystic ovaries
  • 2. Patients with systemic diseases like hypertension, diabetes mellitus, congestive cardiac failure etc.
  • 3. Patients with coagulopathy
  • 4. Liver dysfunction
  • 5. Thyroid dysfunction
  • 6. Patients with malignancy or undiagnosed neoplasm.
  • 7. Patients with history of recent abortion.
  • 8. Patients with active genital tuberculosis.
  • 9. Bleeding from the polyps and erosion.
  • 10. IUCD in utero, pelvic endometriosis.
  • 11. Hb < 8 gm/dl.

研究者

相似试验